PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
124.50M
Better than CGTX's estimated revenue of 117.40M.
-24.90M
Worse than CGTX's estimated ebitda of 0.
0.56
Better than CGTX's estimated eps of -0.23.
16.74M
Better than CGTX's estimated net income of -9.14M.
-24.90M
Worse than CGTX's estimated ebit of 0.
4.61B
Worse than CGTX's estimated sg&a expense of 0.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
Worse than CGTX's revenue growth rate of 0.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than CGTX's ebitda margin of 100.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than CGTX's ebit margin of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to CGTX's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than CGTX's receivables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than CGTX's inventories as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to CGTX's payables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
-29.43%
Better than CGTX's capex as percentage of revenue of 0.00%.
4.99%
Better than CGTX's weighted average cost of capital (wacc) of 8.41%.
5.02%
Better than CGTX's cost of equity of 8.74%.
4.08%
Worse than CGTX's cost of debt of 4.06%.
-0.23
Better than CGTX's beta of 0.99.
30.07M
Better than CGTX's diluted shares outstanding of 39.73M.
1.57M
Worse than CGTX's total debt of 814.00K.
49.31M
Better than CGTX's total equity of 13.11M.
50.89M
Better than CGTX's total capital of 13.92M.
3.09%
Better than CGTX's debt weighting of 5.85%.
96.91%
Better than CGTX's equity weighting of 94.15%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
Equal to CGTX's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than CGTX's net debt of -24.20M.
71.33M
Better than CGTX's equity value of 24.84M.
2.37
Better than CGTX's equity value per share of 0.63.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.